The High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate was convened by the World Health Organization on 5 April 2019.
The objective of the consultation was to discuss key strategies and actions needed to advance the research and development pathway of the M72/AS01E vaccine candidate.
The report of the meeting can be accessed here.
The Global TB Community Advisory Board (TB CAB) and Treatment Action Group (TAG) submitted a statement prior to the meeting.